4basebio says "tier one" partner tests vaccine from its template
(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More
| Price | 712.50p on 09-12-2025 at 08:40:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 725.00p |
| Sell | 700.00p |
| Last Trade: | Sell 7.00 at 704.00p |
| Day's Volume: | 7 |
| Last Close: | 712.50p |
| Open: | 712.50p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 712.50p - 712.50p |
| 52wk Range: | 650.00p - 1,250.00p |
| Market Capitalisation: | £110.33m |
| VWAP: | 704.00p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 7 | 704.00p | Ordinary |
08:30:11 - 09-Dec-25 |
| Unknown* | 2,777 | 685.00p | Negotiated Trade |
15:26:30 - 08-Dec-25 |
| Unknown* | 2,000 | 705.00p | Negotiated Trade |
15:26:26 - 08-Dec-25 |
| Unknown* | 2,777 | 720.00p | Ordinary |
14:41:02 - 08-Dec-25 |
| Sell* | 13 | 701.00p | Ordinary |
14:25:57 - 08-Dec-25 |
| Unknown* | 0 | 725.00p | SI Trade |
13:32:27 - 08-Dec-25 |
| Buy* | 1 | 720.00p | Ordinary |
13:21:20 - 08-Dec-25 |
| Sell* | 300 | 700.25p | Ordinary |
09:59:58 - 08-Dec-25 |
| Sell* | 750 | 701.00p | Ordinary |
09:59:48 - 08-Dec-25 |
| Buy* | 20 | 725.00p | Ordinary |
08:42:42 - 08-Dec-25 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |